VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 222 filers reported holding VERACYTE INC in Q4 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $8,923,207 | +12.4% | 411,777 | +14.9% | 0.00% | 0.0% |
Q1 2024 | $7,941,568 | -12.3% | 358,374 | +8.8% | 0.00% | 0.0% |
Q4 2023 | $9,060,253 | -14.8% | 329,344 | -30.9% | 0.00% | -33.3% |
Q3 2023 | $10,636,873 | +21.4% | 476,349 | +38.5% | 0.00% | +50.0% |
Q2 2023 | $8,762,673 | +1.0% | 344,039 | -11.6% | 0.00% | 0.0% |
Q1 2023 | $8,676,818 | +16.5% | 389,095 | +23.9% | 0.00% | 0.0% |
Q4 2022 | $7,450,603 | +8.8% | 313,974 | -23.9% | 0.00% | 0.0% |
Q3 2022 | $6,849,000 | -91.3% | 412,644 | -89.5% | 0.00% | -91.7% |
Q2 2022 | $78,359,000 | -31.2% | 3,937,666 | -4.7% | 0.02% | -17.2% |
Q1 2022 | $113,908,000 | -32.8% | 4,131,597 | +0.4% | 0.03% | -29.3% |
Q4 2021 | $169,499,000 | -7.2% | 4,114,031 | +4.6% | 0.04% | -10.9% |
Q3 2021 | $182,671,000 | +7.6% | 3,932,650 | -7.4% | 0.05% | +9.5% |
Q2 2021 | $169,777,000 | -24.6% | 4,246,570 | +1.4% | 0.04% | -30.0% |
Q1 2021 | $225,175,000 | +29.0% | 4,189,295 | +17.4% | 0.06% | +17.6% |
Q4 2020 | $174,598,000 | +48.0% | 3,567,585 | -1.7% | 0.05% | +27.5% |
Q3 2020 | $117,963,000 | +41.9% | 3,630,729 | +13.1% | 0.04% | +33.3% |
Q2 2020 | $83,117,000 | +6.1% | 3,209,177 | -0.4% | 0.03% | -9.1% |
Q1 2020 | $78,341,000 | -15.9% | 3,222,564 | -3.5% | 0.03% | +13.8% |
Q4 2019 | $93,194,000 | +20.5% | 3,337,889 | +3.5% | 0.03% | +45.0% |
Q3 2019 | $77,368,000 | -9.1% | 3,223,707 | +8.0% | 0.02% | -9.1% |
Q2 2019 | $85,124,000 | +471.5% | 2,985,745 | +401.5% | 0.02% | +340.0% |
Q1 2019 | $14,896,000 | +941.0% | 595,351 | +423.4% | 0.01% | +400.0% |
Q4 2018 | $1,431,000 | +274.6% | 113,757 | +184.1% | 0.00% | – |
Q3 2018 | $382,000 | +29.9% | 40,046 | +27.3% | 0.00% | – |
Q2 2018 | $294,000 | +302.7% | 31,469 | +139.5% | 0.00% | – |
Q1 2018 | $73,000 | -3.9% | 13,137 | +12.9% | 0.00% | – |
Q4 2017 | $76,000 | -23.2% | 11,636 | +2.6% | 0.00% | – |
Q3 2017 | $99,000 | +8.8% | 11,336 | +4.1% | 0.00% | – |
Q2 2017 | $91,000 | +1720.0% | 10,893 | +2217.7% | 0.00% | – |
Q2 2015 | $5,000 | – | 470 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 425,554 | $11,733,000 | 4.86% |
PERKINS CAPITAL MANAGEMENT INC | 122,980 | $3,391,000 | 2.78% |
Granahan Investment Management | 1,960,736 | $54,057,000 | 1.34% |
EFG Asset Management (North America) Corp. | 291,203 | $8,027,000 | 1.20% |
ARK Investment Management | 8,756,024 | $241,404,000 | 1.01% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 221,661 | $6,111,000 | 0.76% |
ArrowMark Colorado Holdings LLC | 3,089,443 | $85,176,000 | 0.74% |
Granite Investment Partners, LLC | 722,514 | $19,920,000 | 0.68% |
Nikko Asset Management Americas, Inc. | 3,015,041 | $74,833,000 | 0.55% |
Parkman Healthcare Partners LLC | 60,651 | $1,672,000 | 0.49% |